Bevacicumab plus XELOX as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. - Gruenberger,T.; Tamandl,D.; Puhalla,H.; Scheithauer,W.; Zielinski,C.; Gruenberger,B. (J Clin Oncol, 2007)